Axonics, Inc. (AXNX)
USD 70.98
(N/A%)
USD 70.98
(N/A%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 7.77 Million USD | 131.13% |
| 2022 | -47.16 Million USD | 53.64% |
| 2021 | -61.73 Million USD | -13.42% |
| 2020 | -51.29 Million USD | 31.72% |
| 2019 | -78.03 Million USD | -149.29% |
| 2018 | -31.19 Million USD | -80.31% |
| 2017 | -17.33 Million USD | -2.95% |
| 2016 | -16.77 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -8.19 Million USD | -232.89% |
| 2024 Q2 | 9.73 Million USD | 180.95% |
| 2023 Q1 | -8.61 Million USD | -391.04% |
| 2023 Q3 | 5.88 Million USD | -73.61% |
| 2023 Q2 | 22.3 Million USD | 359.02% |
| 2023 FY | - USD | 131.13% |
| 2023 Q4 | 8.18 Million USD | 39.11% |
| 2022 Q3 | -4.31 Million USD | 27.76% |
| 2022 Q4 | 2.95 Million USD | 168.57% |
| 2022 Q2 | -5.97 Million USD | 70.81% |
| 2022 Q1 | -20.46 Million USD | -32.5% |
| 2022 FY | - USD | 53.64% |
| 2021 Q1 | -16.06 Million USD | -47.86% |
| 2021 Q2 | -13.34 Million USD | 16.92% |
| 2021 Q3 | -13.8 Million USD | -3.45% |
| 2021 Q4 | -15.44 Million USD | -11.87% |
| 2021 FY | - USD | -13.42% |
| 2020 Q3 | -8.28 Million USD | 56.19% |
| 2020 Q2 | -18.91 Million USD | -38.23% |
| 2020 Q1 | -13.68 Million USD | 38.33% |
| 2020 Q4 | -10.86 Million USD | -31.07% |
| 2020 FY | - USD | 31.72% |
| 2019 Q3 | -24.42 Million USD | -34.64% |
| 2019 Q1 | -12.58 Million USD | -41.39% |
| 2019 FY | - USD | -149.29% |
| 2019 Q4 | -22.18 Million USD | 9.14% |
| 2019 Q2 | -18.13 Million USD | -44.12% |
| 2018 Q2 | -8.19 Million USD | -31.34% |
| 2018 FY | - USD | -80.31% |
| 2018 Q4 | -8.9 Million USD | -21.82% |
| 2018 Q3 | -7.3 Million USD | 10.88% |
| 2018 Q1 | -6.24 Million USD | -35.3% |
| 2017 Q1 | -4.15 Million USD | 0.0% |
| 2017 Q2 | -4.15 Million USD | 0.0% |
| 2017 Q3 | -4.41 Million USD | -6.26% |
| 2017 Q4 | -4.61 Million USD | -4.52% |
| 2017 FY | - USD | -2.95% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 157.648% |
| Cerus Corporation | -26.53 Million USD | 129.3% |
| OrthoPediatrics Corp. | -8.38 Million USD | 192.769% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 174.086% |
| Talis Biomedical Corporation | -66.04 Million USD | 111.772% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 146.627% |
| Inogen, Inc. | -45.67 Million USD | 117.021% |
| Spectral AI, Inc. | -12.26 Million USD | 163.407% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 116.302% |
| CVRx, Inc. | -38.73 Million USD | 120.074% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 320.38% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 164.219% |
| Orthofix Medical Inc. | -86.98 Million USD | 108.938% |
| Venus Concept Inc. | -26.11 Million USD | 129.774% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 115.622% |
| Bioventus Inc. | -23.07 Million USD | 133.702% |
| BrainsWay Ltd. | -2.31 Million USD | 436.434% |
| Envoy Medical, Inc. | -18.23 Million USD | 142.631% |
| electroCore, Inc. | -17.76 Million USD | 143.778% |
| IceCure Medical Ltd | -15.25 Million USD | 150.974% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 115.628% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 146.127% |
| MaxCyte, Inc. | -44.12 Million USD | 117.619% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 166.137% |
| Nexalin Technology, Inc. | -5.69 Million USD | 236.594% |
| PAVmed Inc | -75.74 Million USD | 110.265% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 114.463% |
| RxSight, Inc. | -41.03 Million USD | 118.946% |
| Sight Sciences, Inc. | -49.41 Million USD | 115.734% |
| SI-BONE, Inc. | -34.44 Million USD | 122.572% |
| TELA Bio, Inc. | -40.63 Million USD | 119.135% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 113.337% |
| Treace Medical Concepts, Inc. | -39 Million USD | 119.932% |
| LivaNova PLC | 39.01 Million USD | 80.072% |
| 908 Devices Inc. | -34.02 Million USD | 122.851% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 107.03% |
| Nemaura Medical Inc. | -7.28 Million USD | 206.696% |
| NeuroPace, Inc. | -22.83 Million USD | 134.05% |
| LENSAR, Inc. | -8.71 Million USD | 189.224% |
| Apyx Medical Corporation | -18.11 Million USD | 142.927% |
| Cutera, Inc. | -136.56 Million USD | 105.693% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 330.03% |
| BioSig Technologies, Inc. | -28.15 Million USD | 127.619% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -209.022% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 137.043% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 97.973% |
| Outset Medical, Inc. | -153.78 Million USD | 105.056% |
| IRIDEX Corporation | -7.44 Million USD | 204.39% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 107.926% |
| IRadimed Corporation | 20.8 Million USD | 62.621% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 196.44% |
| INVO Bioscience, Inc. | -6.88 Million USD | 213.008% |
| Telesis Bio, Inc. | -40.49 Million USD | 119.201% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 78.801% |
| Varex Imaging Corporation | 67.2 Million USD | 88.43% |
| Quipt Home Medical Corp. | 44.07 Million USD | 82.358% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 171.527% |
| Pulmonx Corporation | -55.09 Million USD | 114.113% |
| Dynatronics Corporation | -976 Thousand USD | 896.612% |
| Modular Medical, Inc. | -17.1 Million USD | 145.46% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 153.676% |
| Semler Scientific, Inc. | 23.58 Million USD | 67.04% |
| InMode Ltd. | 196.28 Million USD | 96.039% |
| Bruker Corporation | 599 Million USD | 98.702% |
| Cytosorbents Corporation | -28.81 Million USD | 126.986% |
| DexCom, Inc. | 916.7 Million USD | 99.152% |
| Align Technology, Inc. | 799.03 Million USD | 99.027% |
| Viveve Medical, Inc. | -20.61 Million USD | 137.712% |
| ZimVie Inc. | 91.07 Million USD | 91.463% |
| Movano Inc. | -29.12 Million USD | 126.695% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 276.384% |
| Nexalin Technology, Inc. | -5.69 Million USD | 236.594% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 320.38% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 103.994% |
| Profound Medical Corp. | -27.12 Million USD | 128.665% |
| Insulet Corporation | 323.6 Million USD | 97.597% |
| enVVeno Medical Corporation | -25.01 Million USD | 131.078% |
| Surmodics, Inc. | 1.18 Million USD | -554.461% |
| iCAD, Inc. | -6.56 Million USD | 218.431% |
| Nuwellis, Inc. | -16.35 Million USD | 147.536% |
| Biotricity, Inc. | -8.82 Million USD | 188.069% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 108.027% |
| Aethlon Medical, Inc. | -11.84 Million USD | 165.617% |
| InspireMD, Inc. | -20.91 Million USD | 137.181% |
| PAVmed Inc. | -75.74 Million USD | 110.265% |
| BIOLASE, Inc. | -15.13 Million USD | 151.357% |
| Beyond Air, Inc. | -59.03 Million USD | 113.171% |
| FONAR Corporation | 28.25 Million USD | 72.479% |
| AxoGen, Inc. | -13.32 Million USD | 158.336% |
| Vivani Medical, Inc. | -26.6 Million USD | 129.221% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 68.318% |
| Inari Medical, Inc. | 7.11 Million USD | -9.307% |
| UFP Technologies, Inc. | 72.74 Million USD | 89.312% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 329.636% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 226.3% |
| Tenon Medical, Inc. | -15.52 Million USD | 150.071% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 150.93% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 118.746% |
| AdaptHealth Corp. | -171.09 Million USD | 104.544% |
| Sintx Technologies, Inc. | -6.6 Million USD | 217.803% |
| NanoVibronix, Inc. | -3.43 Million USD | 326.346% |
| Quanterix Corporation | -38.08 Million USD | 120.413% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 171.527% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -25816.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 102.804% |
| TransMedics Group, Inc. | -7.6 Million USD | 202.262% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 135.722% |
| NeuroMetrix, Inc. | -7.09 Million USD | 209.572% |
| Hyperfine, Inc. | -47.06 Million USD | 116.521% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 113.335% |
| Biomerica, Inc. | -5.99 Million USD | 229.735% |
| Bone Biologics Corporation | 479.57 Thousand USD | -1521.237% |
| AVITA Medical, Inc. | -39.56 Million USD | 119.65% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 184.76% |
| Silk Road Medical, Inc | -45.08 Million USD | 117.247% |